Discover 3decision® - Part 2: Creating a collaborative platform for Structure-Based Drug Discovery
As we explained in our previous article, the number of biomolecular structures available for computational analysis is increasing daily, which, for SBDD translates to ever-greater opportunities for discovery.
But wait, is that actually true?
2019-nCov, structurally speaking - part II
As a follow-up to my previous article 2019-nCoV, structurally speaking, I thought I’d share some of the news on the protein structure side and some insights from the structural analyses we’ve done at Discngine.
2019-nCov, structurally speaking
I guess nobody has missed the fact that we are in the middle of a new Coronavirus outbreak. In the beginning, I followed the updates from far, without going in too much detail. That was before I saw a LinkedIn post on a homology model of a 2019-nCoV protease last week.
Using Adobe XD for Scientific Web app development - do your mockups
This time around you won’t see any source code. Sorry about that, next time maybe.
Here I’ll talk more about sometimes overlooked aspects when developing applications for R&D in life sciences. So I guess this post might be useful to our competitors or people developing applications within large corporations in the life science & pharma industry … anyway ;)
I’ll take the example of our current 3decision developments. You might have heard or read about 3decision already before. If not, check it out - 3decision .. it’s super cool!
Tethered minimization of small molecules with RDKit
I think that’s my first RDKit post! So reason to celebrate!
Here' I’ll focus on a very nice feature available in Open Source Software and very useful in daily structure based but even ligand based drug design tasks.
The problem
How can I dock small molecules into a receptor and avoid as much as possible the “what is the right pose” problem?